Patient Research Findings
Based on population statistics, 10 million women in the U.S. between the ages of 35-49 are suffering from heavy menstrual bleeding and have completed childbearing, making them potential candidates for the NovaSure® procedure.However, most women (88%) are unaware that a treatment for heavy menstrual bleeding exists. For the women who have been educated on the treatment options, endometrial ablation is rated most favorably among the continuum of heavy menstrual bleeding treatments. Of all endometrial ablation treatments, NovaSure is rated most favorably.
